QJE — Muscular Dystrophy Newborn Screening Test Class II

FDA Device Classification

Classification Details

Product Code
QJE
Device Class
Class II
Regulation Number
862.1506
Submission Type
Review Panel
CH
Medical Specialty
Clinical Chemistry
Implant
No

Definition

A muscular dystrophy newborn screening test is intended to measure creatine kinase levels obtained from dried blood spot specimens on filter paper from newborns as an aid in screening newborns for muscular dystrophy.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
DEN180056perkinelmerGSP Neonatal Creatine Kinase - MM kitDecember 12, 2019